The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease
Open accessAbstract
IMPORTANCE: Epileptic activity associated with Alzheimer disease (AD) deserves increased attention because it has a harmful impact on these patients, can easily go unrecognized and untreated, and may reflect pathogenic processes that also contribute to other aspects of the illness. We report key features of AD-related seizures and epileptiform activity that are instructive for clinical practice and highlight similarities between AD and transgenic animal models of the disease. OBJECTIVE: To describe common clinical characteristics and treatment outcomes of patients with amnestic mild cognitive impairment (aMCI) or early AD who also have epilepsy or subclinical epileptiform activity. DESIGN: Retrospective observational study from 2007 to 2012. SETTING Memory and Aging Center, University of California, San Francisco. PATIENTS: We studied 54 patients with a diagnosis of aMCI plus epilepsy (n = 12), AD plus epilepsy (n = 35), and AD plus subclinical epileptiform activity (n = 7). MAIN OUTCOMES AND MEASURES: Clinical and demographic data, electroencephalogram (EEG) readings, and treatment responses to antiepileptic medications. RESULTS: Patients with aMCI who had epilepsy presented with symptoms of cognitive decline 6.8 years earlier than patients with aMCI who did not have epilepsy (64.3 vs 71.1 years; P = .02). Patients with AD who had epilepsy presented with cognitive decline 5.5 years earlier than patients with AD who did not have epilepsy (64.8 vs 70.3 years; P = .001). Patients with AD who had subclinical epileptiform activity also had an early onset of cognitive decline (58.9 years). The timing of seizure onset in patients with aMCI and AD was nonuniform (P < .001), clustering near the onset of cognitive decline. Epilepsies were most often complex partial seizures (47%) and more than half were nonconvulsive (55%). Serial or extended EEG monitoring appeared to be more effective than routine EEG at detecting interictal and subclinical epileptiform activity. Epileptic foci were predominantly unilateral and temporal. Of the most commonly prescribed antiepileptics, treatment outcomes appeared to be better for lamotrigine and levetiracetam than for phenytoin. CONCLUSIONS AND RELEVANCE: Common clinical features of patients with aMCI- or AD-associated epilepsy at our center included early age at onset of cognitive decline, early incidence of seizures in the disease course, unilateral temporal epileptic foci detected by serial/extended EEG, transient cognitive dysfunction, and good seizure control and tolerability with lamotrigine and levetiracetam. Careful identification and treatment of epilepsy in such patients may improve their clinical course.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Berg, A. T., Berkovic, S. F., Brodie, M. J., Buchhalter, J., Cross, J. H., Van Emde Boas, W., Engel, J., French, J., Glauser, T. A., Mathern, G. W., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02522.x · Cited by 4,363
Fisher, R. S., Boas, W. V. E., Blume, W., Elger, C., Genton, P., Lee, P., & Engel, J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.66104.x · Cited by 3,671
Beghi, E., Berg, A., Carpio, A., Forsgren, L., Hesdorffer, D. C., Hauser, W. A., Malmgren, K., Shinnar, S., Temkin, N., Thurman, D., et al. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00273_1.x · Cited by 2,296
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,851
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
Self-citationAmyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
Self-citationMcKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (2011) · Neurology · doi:10.1212/01.wnl.0000400650.92875.cf · Cited by 1,495
Verret, L., Mann, E. O., Hang, G. B., Barth, A. M. I., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A. C., Mody, I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.046 · Cited by 1,216
Self-citationClusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer’s Disease
Busche, M. A., Eichhoff, G., Adelsberger, H., Abramowski, D., Wiederhold, K.-H., Haass, C., Staufenbiel, M., Konnerth, A., & Garaschuk, O. (2008) · Science · doi:10.1126/science.1162844 · Cited by 1,125
A population-based study of seizures after traumatic brain injuries
Annegers, J. F., Hauser, W. A., Coan, S. P., & Rocca, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801013380104 · Cited by 1,090
Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981
Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment
Bakker, A., Krauss, G. L., Albert, M. S., Speck, C. L., Jones, L. R., Stark, C. E., Yassa, M. A., Bassett, S. S., Shelton, A. L., & Gallagher, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.023 · Cited by 908
Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias
Plassman, B. L., Havlik, R. J., Steffens, D. C., Helms, M. J., Newman, T. N., Drosdick, D., Phillips, C., Gau, B. A., Welsh–Bohmer, K. A., Burke, J. R., et al. (2000) · Neurology · doi:10.1212/wnl.55.8.1158 · Cited by 896
Busche, M. A., Chen, X., Henning, H. A., Reichwald, J., Staufenbiel, M., Sakmann, B., & Konnerth, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206171109 · Cited by 715
Epilepsy and Cognitive Impairments in Alzheimer Disease
Palop, J. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.15 · Cited by 684
Sanchez, P. E., Zhu, L., Verret, L., Vossel, K. A., Orr, A. G., Cirrito, J. R., Devidze, N., Ho, K., Yu, G.-Q., Palop, J. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121081109 · Cited by 638
Self-citationIncidence and Predictors of Seizures in Patients with Alzheimer's Disease
Amatniek, J. C., Hauser, W. A., DelCastillo‐Castaneda, C., Jacobs, D. M., Marder, K., Bell, K., Albert, M., Brandt, J., & Stern, Y. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00554.x · Cited by 590
Mayeux, R., Ottman, R., Maestre, G., Ngai, C., Tang, M.-X., Ginsberg, H., Chun, M., Tycko, B., & Shelanski, M. (1995) · Neurology · doi:10.1212/wnl.45.3.555 · Cited by 590
Leach, M. J., Marden, C. M., & Miller, A. A. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb03573.x · Cited by 549
11 C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
Rabinovici, G. D., Furst, A. J., O'Neil, J. P., Racine, C. A., Mormino, E. C., Baker, S. L., Chetty, S., Patel, P., Pagliaro, T. A., Klunk, W. E., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000259035.98480.ed · Cited by 410
Self-citationPhenotype associated with APP duplication in five families
Cabrejo, L., Guyant-Marechal, L., Laquerriere, A., Vercelletto, M., De La Fourniere, F., Thomas-Anterion, C., Verny, C., Letournel, F., Pasquier, F., Vital, A., et al. (2006) · Brain · doi:10.1093/brain/awl237 · Cited by 343
Seizures and myoclonus in patients with Alzheimer's disease
Hauser, W. A., Morris, M. L., Heston, L. L., & Anderson, V. E. (1986) · Neurology · doi:10.1212/wnl.36.9.1226 · Cited by 336
Dementia and adult-onset unprovoked seizures
Hesdorffer, D. C., Hauser, W. A., Annegers, J. F., Kokmen, E., & Rocca, W. A. (1996) · Neurology · doi:10.1212/wnl.46.3.727 · Cited by 311
Seizures in Alzheimer Disease: Who, When, and How Common?
Scarmeas, N., Honig, L. S., Choi, H., Cantero, J., Brandt, J., Blacker, D., Albert, M., Amatniek, J. C., Marder, K., Bell, K., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.130 · Cited by 294
Frontotemporal dementia progresses to death faster than Alzheimer disease
Roberson, E. D., Hesse, J. H., Rose, K. D., Slama, H., Johnson, J. K., Yaffe, K., Forman, M. S., Miller, C. A., Trojanowski, J. Q., Kramer, J. H., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000173837.82820.9f · Cited by 290
Self-citationThe syndrome of transient epileptic amnesia
Butler, C. R., Graham, K. S., Hodges, J. R., Kapur, N., Wardlaw, J. M., & Zeman, A. Z. J. (2007) · Annals of Neurology · doi:10.1002/ana.21111 · Cited by 281
Putcha, D., Brickhouse, M., O'Keefe, K., Sullivan, C., Rentz, D., Marshall, G., Dickerson, B., & Sperling, R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4740-11.2011 · Cited by 258
Advanced Alzheimer's Disease Is a Risk Factor for Late-Onset Seizures
Romanelli, M. F., Morris, J. C., Ashkin, K., & Coben, L. A. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530080029006 · Cited by 242
Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
Tariot, P. N. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.72 · Cited by 223
Seizures in Elderly Patients with Dementia: Epidemiology and Management
Mendez, M. F., & Lim, G. T. H. (2003) · Drugs & Aging · doi:10.2165/00002512-200320110-00001 · Cited by 219
Cumbo, E., & Ligori, L. D. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.01.015 · Cited by 216
Chronic divalproex sodium use and brain atrophy in Alzheimer disease
Fleisher, A. S., Truran, D., Mai, J. T., Langbaum, J. B. S., Aisen, P. S., Cummings, J. L., Jack, C. R., Weiner, M. W., Thomas, R. G., Schneider, L. S., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318230a16c · Cited by 177
Koh, M. T., Haberman, R. P., Foti, S., McCown, T. J., & Gallagher, M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.207 · Cited by 169
Recurrent seizures in patients with dementia: Frequency, seizure types, and treatment outcome
Rao, S. C., Dove, G., Cascino, G. D., & Petersen, R. C. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.08.012 · Cited by 167
Neurologic Signs in Alzheimer's Disease: Results of a Prospective Clinical and Neuropathologic Study
Förstl, H., Burns, A., Levy, R. I., Cairns, N., Luthert, P., & Lantos, P. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530340054018 · Cited by 150
Incidence of New-Onset Seizures in Mild to Moderate Alzheimer Disease
Irizarry, M. C., Jin, S., He, F., Emond, J. A., Raman, R., Thomas, R. G., Sano, M., Quinn, J. F., Tariot, P. N., Galasko, D. R., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.830 · Cited by 145
Effect of Seizures on Progression of Dementia of the Alzheimer Type
Volicer, L., Smith, S. J., & Volicer, B. J. (1995) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106956 · Cited by 134
Meehan, A. L., Yang, X., McAdams, B. D., Yuan, L., & Rothman, S. M. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00279.2011 · Cited by 125
Пономарева, Н. В., Коровайцева, Г. И., & Rogaev, E. I. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.019 · Cited by 102
Epileptic Seizures in Elderly Patients with Dementia
McAreavey, M. J., Ballinger, B. R., & Fenton, G. W. (1992) · Epilepsia · doi:10.1111/j.1528-1157.1992.tb02343.x · Cited by 100
Pure hippocampal sclerosis: A rare cause of dementia mimicking Alzheimer’s disease
Ala, T. A., Beh, G. O., & Frey, W. H. (2000) · Neurology · doi:10.1212/wnl.54.4.843 · Cited by 91
Belcastro, V., Costa, C., Galletti, F., Pisani, F., Calabresi, P., & Parnetti, L. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01907.x · Cited by 87
Prevalence and Clinical Significance of Epileptiform EEG Discharges in a Large Memory Clinic Cohort
Liedorp, M., Stam, C. J., van der Flier, W. M., Pijnenburg, Y. A. L., & Scheltens, P. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000278620 · Cited by 68
Alzheimer‘s Disease and Epilepsy: Insight From Animal Models
Scharfman, H. E. (2012) · Future Neurology · doi:10.2217/fnl.12.8 · Cited by 61
Pure hippocampal sclerosis: A rare cause of dementia mimicking Alzheimer’s disease
Jellinger, K. (2000) · Neurology · doi:10.1212/wnl.55.5.735-d · Cited by 57
Adverse effects of phenytoin given for late-onset seizures in adults with Down syndrome
Tsiouris, J. A., Patti, P. J., Tipu, O., & Raguthu, S. (2002) · Neurology · doi:10.1212/wnl.59.5.779 · Cited by 36
Epileptic Amnesic Syndrome revealing Alzheimer's disease
Cretin, B., Blanc, F., Gaultier, C., & Sellal, F. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.08.002 · Cited by 27
Cited by
Network abnormalities and interneuron dysfunction in Alzheimer disease
Palop, J. J., & Mucke, L. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.141 · Cited by 1,022
Self-citationβ-Hydroxybutyrate: A Signaling Metabolite
Newman, J. C., & Verdin, E. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064916 · Cited by 872
A vicious cycle of β amyloid−dependent neuronal hyperactivation
Zott, B., Simon, M. M., Hong, W., Unger, F., Chen-Engerer, H.-J., Frosch, M. P., Sakmann, B., Walsh, D. M., & Konnerth, A. (2019) · Science · doi:10.1126/science.aay0198 · Cited by 640
Epileptic activity in Alzheimer’s disease: Causes and clinical relevance
Vossel, K. A., Tartaglia, M. C., Nygaard, H. B., Zeman, A. Z., & Miller, B. L. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30044-3 · Cited by 590
Self-citationThe road to restoring neural circuits for the treatment of Alzheimer's disease
Canter, R. G., Penney, J., & Tsai, L.-H. (2016) · Nature · doi:10.1038/nature20412 · Cited by 565
Metadata
- Authors
- Vossel, K. A., Beagle, A. J., Rabinovici, G. D., Shu, H., Lee, S. E., Naasan, G., Hegde, M., Cornes, S. B., Henry, M. L., Nelson, A. B., Seeley, W. W., Geschwind, M. D., Gorno-Tempini, M. L., Shih, T., Kirsch, H. E., Garcia, P. A., Miller, B. L., & Mucke, L.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2013-09-01
- Volume
- 70
- Issue
- 9
- Pages
- 1158
- ISSN
- 2168-6149 (ISSN-L)
- OpenAlex
- W1970910654
- Cited by
- 741
- References
- 51
- FWCI
- 25.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.